Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-06-20500CALL0 0331.77TRUE00
2025-06-20550CALL0 0306.53TRUE00
2025-06-20600CALL0 0287.22TRUE00
2025-06-20650CALL0 0269.37TRUE00
2025-06-20700CALL0 1246.76TRUE00
2025-06-20750CALL0 1228.78TRUE00
2025-06-20800CALL0 0212TRUE00
2025-06-20850CALL0 0196.27TRUE00
2025-06-20900CALL0 0183.82TRUE00
2025-06-20950CALL0 0171.84TRUE00
2025-06-201000CALL0 1156.15TRUE00
2025-06-201050CALL0 1143.27TRUE00
2025-06-201100CALL0 668.65TRUE00
2025-06-201150CALL0 2120.77TRUE00
2025-06-201200CALL0 357.9TRUE00
2025-06-201250CALL0 057.13TRUE00
2025-06-201300CALL0 955.44TRUE00
2025-06-2013529.35CALL0 551.51TRUE00
2025-06-2014024.95CALL0 20753.87TRUE00
2025-06-201450CALL0 851.2TRUE00
2025-06-2015016.8CALL0 649.93TRUE00
2025-06-201550CALL0 1148.34TRUE00
2025-06-201609.69CALL15 17953.02TRUE9.690
2025-06-201655.24CALL0 2646.46FALSE00
2025-06-201702.15CALL0 1144.54FALSE00
2025-06-201752.95CALL10 4446.91FALSE2.950
2025-06-201801.15CALL0 142645.34FALSE00
2025-06-201850CALL0 1049.99FALSE00
2025-06-201900CALL0 455.05FALSE00
2025-06-201950CALL0 160.4FALSE00
2025-06-202000CALL0 165.64FALSE00
2025-06-202100CALL0 275.85FALSE00
2025-06-202200CALL0 085.03FALSE00
2025-06-202300CALL0 894.28FALSE00
2025-06-202400CALL0 4102.43FALSE00
2025-06-20500PUT0 0296.09FALSE00
2025-06-20550PUT0 0273.82FALSE00
2025-06-20600PUT0 2253.61FALSE00
2025-06-20650PUT0 2235.11FALSE00
2025-06-20700PUT0 1218.04FALSE00
2025-06-20750PUT0 0202.18FALSE00
2025-06-20800PUT0 0187.36FALSE00
2025-06-20850PUT0 0173.42FALSE00
2025-06-20900PUT0 0160.26FALSE00
2025-06-20950PUT0 5147.78FALSE00
2025-06-201000PUT0 0135.89FALSE00
2025-06-201050PUT0 0124.51FALSE00
2025-06-201100PUT0 1114.2FALSE00
2025-06-201150PUT0 30104.19FALSE00
2025-06-201200PUT0 132094.44FALSE00
2025-06-201250PUT0 5085.35FALSE00
2025-06-201300PUT0 2776.76FALSE00
2025-06-201351.72PUT0 768.84FALSE00
2025-06-201402.12PUT0 20760.95FALSE00
2025-06-201450PUT0 4553.74FALSE00
2025-06-201503.6PUT0 12850.49FALSE00
2025-06-201556PUT0 249.23FALSE00
2025-06-201600PUT0 348.35FALSE00
2025-06-201650PUT0 846.46TRUE00
2025-06-201700PUT0 20043.11TRUE00
2025-06-201750PUT0 041.99TRUE00
2025-06-201800PUT0 036.8TRUE00
2025-06-201850PUT0 038.93TRUE00
2025-06-201900PUT0 038.71TRUE00
2025-06-201950PUT0 048.33TRUE00
2025-06-202000PUT0 052.21TRUE00
2025-06-202100PUT0 26958.12TRUE00
2025-06-202200PUT0 066.77TRUE00
2025-06-202300PUT0 074.88TRUE00
2025-06-202400PUT0 082.53TRUE00
2025-07-18700CALL0 0159.19TRUE00
2025-07-18750CALL0 0147.3TRUE00
2025-07-18800CALL0 0138TRUE00
2025-07-18850CALL0 0127.53TRUE00
2025-07-18900CALL0 0120.74TRUE00
2025-07-18950CALL0 0109.83TRUE00
2025-07-181000CALL0 1102.27TRUE00
2025-07-181050CALL0 042.8TRUE00
2025-07-181100CALL0 050.79TRUE00
2025-07-181150CALL0 048.79TRUE00
2025-07-181200CALL0 049.62TRUE00
2025-07-181250CALL0 353.15TRUE00
2025-07-181300CALL0 051.65TRUE00
2025-07-181350CALL0 050.23TRUE00
2025-07-181400CALL0 12549.65TRUE00
2025-07-181450CALL0 048.45TRUE00
2025-07-181500CALL0 10048.45TRUE00
2025-07-181550CALL0 148.02TRUE00
2025-07-181600CALL0 246.75TRUE00
2025-07-1816510.69CALL15 1647.81FALSE-0.26-0.02
2025-07-181706.3CALL0 35244.47FALSE00
2025-07-181755.95CALL0 10843.84FALSE00
2025-07-181804.3CALL0 342.93FALSE00
2025-07-181850CALL0 141.38FALSE00
2025-07-181902.7CALL0 141.18FALSE00
2025-07-181951.95CALL0 043.17FALSE00
2025-07-182001.4CALL0 15145.3FALSE00
2025-07-182100CALL0 350.22FALSE00
2025-07-182200CALL0 155.53FALSE00
2025-07-182300CALL0 761.01FALSE00
2025-07-182400CALL0 366.32FALSE00
2025-07-18700PUT0 0141.21FALSE00
2025-07-18750PUT0 0130.97FALSE00
2025-07-18800PUT0 0121.4FALSE00
2025-07-18850PUT0 0112.4FALSE00
2025-07-18900PUT0 5103.91FALSE00
2025-07-18950PUT0 196.33FALSE00
2025-07-181000PUT0 589.07FALSE00
2025-07-181050PUT0 17566.44FALSE00
2025-07-181100PUT0 075.34FALSE00
2025-07-181150PUT0 169.48FALSE00
2025-07-181200PUT0 063.98FALSE00
2025-07-181250PUT0 157.9FALSE00
2025-07-181300PUT0 153.37FALSE00
2025-07-181350PUT0 050.83FALSE00
2025-07-181400PUT0 20047.93FALSE00
2025-07-181450PUT0 046.82FALSE00
2025-07-181505.95PUT0 1546.75FALSE00
2025-07-181557.9PUT0 1446.54FALSE00
2025-07-181600PUT0 145.84FALSE00
2025-07-1816513.2PUT0 444.88TRUE00
2025-07-181700PUT0 043.18TRUE00
2025-07-181750PUT0 043.15TRUE00
2025-07-181800PUT0 040.96TRUE00
2025-07-181850PUT0 040.51TRUE00
2025-07-181900PUT0 039.47TRUE00
2025-07-181950PUT0 038.67TRUE00
2025-07-182000PUT0 041.48TRUE00
2025-07-182100PUT0 044.19TRUE00
2025-07-182200PUT0 048.11TRUE00
2025-07-182300PUT0 053.83TRUE00
2025-07-182400PUT0 059.23TRUE00
2025-09-19750CALL0 099.39TRUE00
2025-09-19800CALL0 041.93TRUE00
2025-09-19850CALL0 050.33TRUE00
2025-09-19900CALL0 050.53TRUE00
2025-09-19950CALL0 050.62TRUE00
2025-09-191000CALL0 051.22TRUE00
2025-09-191050CALL0 049.64TRUE00
2025-09-191100CALL0 052.61TRUE00
2025-09-191150CALL0 054.69TRUE00
2025-09-191200CALL0 050.58TRUE00
2025-09-191250CALL0 052.99TRUE00
2025-09-191300CALL0 051.62TRUE00
2025-09-191350CALL0 051.53TRUE00
2025-09-191400CALL0 051.03TRUE00
2025-09-191450CALL0 050.52TRUE00
2025-09-191500CALL0 149.99TRUE00
2025-09-191550CALL0 049.27TRUE00
2025-09-191600CALL0 048.37TRUE00
2025-09-191650CALL0 047.86FALSE00
2025-09-191700CALL0 047.57FALSE00
2025-09-191750CALL0 346.69FALSE00
2025-09-191800CALL0 245.2FALSE00
2025-09-191850CALL0 044.83FALSE00
2025-09-191907CALL0 143.71FALSE00
2025-09-191950CALL0 043.39FALSE00
2025-09-192000CALL0 50142.23FALSE00
2025-09-192100CALL0 041.18FALSE00
2025-09-192200CALL0 040.75FALSE00
2025-09-192300CALL0 042.6FALSE00
2025-09-192400CALL0 50144.89FALSE00
2025-09-192500CALL0 047.47FALSE00
2025-09-19750PUT0 087.22FALSE00
2025-09-19800PUT0 081.28FALSE00
2025-09-19850PUT0 075.67FALSE00
2025-09-19900PUT0 070.35FALSE00
2025-09-19950PUT0 065.87FALSE00
2025-09-191000PUT0 061.51FALSE00
2025-09-191050PUT0 057.74FALSE00
2025-09-191100PUT0 054.61FALSE00
2025-09-191150PUT0 050.97FALSE00
2025-09-191200PUT0 049.14FALSE00
2025-09-191250PUT0 049.22FALSE00
2025-09-191300PUT0 050.09FALSE00
2025-09-191350PUT0 048.57FALSE00
2025-09-191400PUT0 049.64FALSE00
2025-09-191450PUT0 048.9FALSE00
2025-09-191500PUT0 048.14FALSE00
2025-09-191550PUT0 047.79FALSE00
2025-09-191600PUT0 047.47FALSE00
2025-09-191650PUT0 046.5TRUE00
2025-09-191700PUT0 046.43TRUE00
2025-09-191750PUT0 045.3TRUE00
2025-09-191800PUT0 045.52TRUE00
2025-09-191850PUT0 043.95TRUE00
2025-09-191900PUT0 042.52TRUE00
2025-09-191950PUT0 041.67TRUE00
2025-09-192000PUT0 040.72TRUE00
2025-09-192100PUT0 039.31TRUE00
2025-09-192200PUT0 039.98TRUE00
2025-09-192300PUT0 041.58TRUE00
2025-09-192400PUT0 044.65TRUE00
2025-09-192500PUT0 048.38TRUE00
2025-10-17750CALL0 089.71TRUE00
2025-10-17800CALL0 054.03TRUE00
2025-10-17850CALL0 048.66TRUE00
2025-10-17900CALL0 052.11TRUE00
2025-10-17950CALL0 049.26TRUE00
2025-10-171000CALL0 049.16TRUE00
2025-10-171050CALL0 049.06TRUE00
2025-10-171100CALL0 050.71TRUE00
2025-10-171150CALL0 049.96TRUE00
2025-10-171200CALL0 051.4TRUE00
2025-10-171250CALL0 050.37TRUE00
2025-10-171300CALL0 050TRUE00
2025-10-171350CALL0 050.06TRUE00
2025-10-171400CALL0 049.44TRUE00
2025-10-171450CALL0 048.89TRUE00
2025-10-171500CALL0 047.51TRUE00
2025-10-171550CALL0 048.1TRUE00
2025-10-171600CALL0 047.32TRUE00
2025-10-171650CALL0 046.69FALSE00
2025-10-171700CALL0 046.19FALSE00
2025-10-171750CALL0 046.2FALSE00
2025-10-1718013.8CALL0 345.62FALSE00
2025-10-171850CALL0 145.08FALSE00
2025-10-171900CALL0 044.07FALSE00
2025-10-171950CALL0 043.67FALSE00
2025-10-172000CALL0 043.1FALSE00
2025-10-172100CALL0 042.08FALSE00
2025-10-172200CALL0 241.23FALSE00
2025-10-172300CALL0 240.36FALSE00
2025-10-172400CALL0 141.56FALSE00
2025-10-172500CALL0 043.21FALSE00
2025-10-17750PUT0 078.21FALSE00
2025-10-17800PUT0 073.24FALSE00
2025-10-17850PUT0 068.21FALSE00
2025-10-17900PUT0 064FALSE00
2025-10-17950PUT0 060.18FALSE00
2025-10-171000PUT0 056.66FALSE00
2025-10-171050PUT0 153.56FALSE00
2025-10-171100PUT0 151.83FALSE00
2025-10-171150PUT0 050.17FALSE00
2025-10-171200PUT0 050.44FALSE00
2025-10-171250PUT0 249.63FALSE00
2025-10-171300PUT0 248.74FALSE00
2025-10-171356PUT0 148.1FALSE00
2025-10-171400PUT0 047.86FALSE00
2025-10-171450PUT0 047.74FALSE00
2025-10-171500PUT0 046.88FALSE00
2025-10-171550PUT0 046.83FALSE00
2025-10-171600PUT0 046.21FALSE00
2025-10-171650PUT0 045.69TRUE00
2025-10-171700PUT0 046.16TRUE00
2025-10-171750PUT0 144.97TRUE00
2025-10-171800PUT0 044.28TRUE00
2025-10-171850PUT0 043.84TRUE00
2025-10-171900PUT0 042.87TRUE00
2025-10-171950PUT0 042.2TRUE00
2025-10-172000PUT0 041.52TRUE00
2025-10-172100PUT0 040.47TRUE00
2025-10-172200PUT0 039.26TRUE00
2025-10-172300PUT0 041.22TRUE00
2025-10-172400PUT0 041.65TRUE00
2025-10-172500PUT0 045.1TRUE00
2025-12-19600CALL0 058.35TRUE00
2025-12-19650CALL0 049.39TRUE00
2025-12-19700CALL0 054.45TRUE00
2025-12-19750CALL0 149.86TRUE00
2025-12-19800CALL0 051.56TRUE00
2025-12-19850CALL0 051.36TRUE00
2025-12-19900CALL0 049.15TRUE00
2025-12-19950CALL0 048.76TRUE00
2025-12-191000CALL0 050.92TRUE00
2025-12-191050CALL0 051.28TRUE00
2025-12-191100CALL0 048.65TRUE00
2025-12-191150CALL0 048.83TRUE00
2025-12-191200CALL0 050.58TRUE00
2025-12-191250CALL0 3849.57TRUE00
2025-12-191300CALL0 148.67TRUE00
2025-12-191350CALL0 148.94TRUE00
2025-12-191400CALL0 348.57TRUE00
2025-12-191450CALL0 248.53TRUE00
2025-12-191500CALL0 248.18TRUE00
2025-12-191550CALL0 046.8TRUE00
2025-12-191600CALL0 6647.07TRUE00
2025-12-191650CALL0 047.06FALSE00
2025-12-191700CALL0 8146.29FALSE00
2025-12-191750CALL0 045.81FALSE00
2025-12-191800CALL0 1245.96FALSE00
2025-12-191850CALL0 1545.37FALSE00
2025-12-191900CALL0 145.12FALSE00
2025-12-191950CALL0 6044.9FALSE00
2025-12-192000CALL0 5543.95FALSE00
2025-12-192100CALL0 1043.44FALSE00
2025-12-192200CALL0 4542.19FALSE00
2025-12-192300CALL0 041.45FALSE00
2025-12-192400CALL0 240.49FALSE00
2025-12-192500CALL0 240.18FALSE00
2025-12-19600PUT0 081.65FALSE00
2025-12-19650PUT0 176.14FALSE00
2025-12-19700PUT0 071.04FALSE00
2025-12-19750PUT0 066.28FALSE00
2025-12-19800PUT0 2062.36FALSE00
2025-12-19850PUT0 158.84FALSE00
2025-12-19900PUT0 2155.64FALSE00
2025-12-19950PUT0 152.87FALSE00
2025-12-191000PUT0 150.25FALSE00
2025-12-191050PUT0 148.48FALSE00
2025-12-191100PUT0 148.02FALSE00
2025-12-191150PUT0 049.38FALSE00
2025-12-191200PUT0 248.86FALSE00
2025-12-191250PUT0 148.2FALSE00
2025-12-191300PUT0 147.72FALSE00
2025-12-191350PUT0 147.64FALSE00
2025-12-191400PUT0 047.59FALSE00
2025-12-191450PUT0 146.96FALSE00
2025-12-191500PUT0 047.45FALSE00
2025-12-191550PUT0 047.04FALSE00
2025-12-191600PUT0 046.05FALSE00
2025-12-191650PUT0 045.98TRUE00
2025-12-191700PUT0 045.54TRUE00
2025-12-191750PUT0 045.26TRUE00
2025-12-191800PUT0 045.16TRUE00
2025-12-191850PUT0 16444.51TRUE00
2025-12-191900PUT0 043.61TRUE00
2025-12-191950PUT0 043.69TRUE00
2025-12-192000PUT0 1643.45TRUE00
2025-12-192100PUT0 142.29TRUE00
2025-12-192200PUT0 240.82TRUE00
2025-12-192300PUT0 039.55TRUE00
2025-12-192400PUT0 137.97TRUE00
2025-12-192500PUT0 040.44TRUE00
2026-01-16750CALL0 053.7TRUE00
2026-01-16800CALL0 052.96TRUE00
2026-01-16850CALL0 052.66TRUE00
2026-01-16900CALL0 052.48TRUE00
2026-01-16950CALL0 054.52TRUE00
2026-01-161000CALL0 053.89TRUE00
2026-01-161050CALL0 053.48TRUE00
2026-01-161100CALL0 053.78TRUE00
2026-01-161150CALL0 052.77TRUE00
2026-01-161200CALL0 053.04TRUE00
2026-01-161250CALL0 052.51TRUE00
2026-01-161300CALL0 051.61TRUE00
2026-01-161350CALL0 051.04TRUE00
2026-01-161400CALL0 050.5TRUE00
2026-01-161450CALL0 049.75TRUE00
2026-01-161500CALL0 849.25TRUE00
2026-01-161550CALL0 048.65TRUE00
2026-01-1616027.35CALL0 448.38TRUE00
2026-01-1616524.85CALL0 2147.1FALSE00
2026-01-161700CALL0 746.55FALSE00
2026-01-161750CALL0 046.01FALSE00
2026-01-161800CALL0 546.26FALSE00
2026-01-161850CALL0 5046.05FALSE00
2026-01-161900CALL0 245.39FALSE00
2026-01-161950CALL0 045.36FALSE00
2026-01-162000CALL0 245.2FALSE00
2026-01-162100CALL0 044.38FALSE00
2026-01-162200CALL0 043.63FALSE00
2026-01-162300CALL0 043.2FALSE00
2026-01-162400CALL0 142.32FALSE00
2026-01-162500CALL0 041.96FALSE00
2026-01-16750PUT0 063.67FALSE00
2026-01-16800PUT0 060.35FALSE00
2026-01-16850PUT0 057.53FALSE00
2026-01-16900PUT0 054.88FALSE00
2026-01-16950PUT0 052.36FALSE00
2026-01-161000PUT0 051.24FALSE00
2026-01-161050PUT0 052.62FALSE00
2026-01-161100PUT0 052.22FALSE00
2026-01-161150PUT0 051.08FALSE00
2026-01-161200PUT0 050.78FALSE00
2026-01-161250PUT0 050.63FALSE00
2026-01-161300PUT0 549.9FALSE00
2026-01-161350PUT0 2749.73FALSE00
2026-01-161400PUT0 1949.39FALSE00
2026-01-161450PUT0 1448.92FALSE00
2026-01-1615018.6PUT0 148FALSE00
2026-01-161550PUT0 047.43FALSE00
2026-01-161600PUT0 047.65FALSE00
2026-01-161650PUT0 1647.03TRUE00
2026-01-161700PUT0 046.4TRUE00
2026-01-161750PUT0 046.16TRUE00
2026-01-161800PUT0 045.82TRUE00
2026-01-161850PUT0 045.18TRUE00
2026-01-161900PUT0 044.53TRUE00
2026-01-161950PUT0 044.42TRUE00
2026-01-162000PUT0 044.02TRUE00
2026-01-162100PUT0 043.18TRUE00
2026-01-162200PUT0 042.03TRUE00
2026-01-162300PUT0 041.99TRUE00
2026-01-162400PUT0 040.81TRUE00
2026-01-162500PUT0 040.06TRUE00
2026-06-18800CALL0 062.32TRUE00
2026-06-18850CALL0 061.27TRUE00
2026-06-18900CALL0 060.16TRUE00
2026-06-18950CALL0 059.82TRUE00
2026-06-181000CALL0 058.85TRUE00
2026-06-181050CALL0 058.65TRUE00
2026-06-181100CALL0 059.02TRUE00
2026-06-181150CALL0 058.32TRUE00
2026-06-181200CALL0 058.31TRUE00
2026-06-181250CALL0 056.99TRUE00
2026-06-181300CALL0 056.54TRUE00
2026-06-181350CALL0 056.38TRUE00
2026-06-181400CALL0 1056TRUE00
2026-06-181450CALL0 055.45TRUE00
2026-06-181500CALL0 055.16TRUE00
2026-06-181550CALL0 054.7TRUE00
2026-06-181600CALL0 054.08TRUE00
2026-06-181650CALL0 054.12FALSE00
2026-06-181700CALL0 054FALSE00
2026-06-181750CALL0 053.35FALSE00
2026-06-181800CALL0 053.32FALSE00
2026-06-181850CALL0 053.17FALSE00
2026-06-181900CALL0 052.13FALSE00
2026-06-181950CALL0 052.1FALSE00
2026-06-182000CALL0 051.94FALSE00
2026-06-182100CALL0 051.29FALSE00
2026-06-182200CALL0 050.97FALSE00
2026-06-182300CALL0 050.16FALSE00
2026-06-18800PUT0 057.86FALSE00
2026-06-18850PUT0 056.91FALSE00
2026-06-18900PUT0 056.56FALSE00
2026-06-18950PUT0 056.34FALSE00
2026-06-181000PUT0 055.67FALSE00
2026-06-181050PUT0 056.83FALSE00
2026-06-181100PUT0 055.78FALSE00
2026-06-181150PUT0 055.38FALSE00
2026-06-181200PUT0 054.84FALSE00
2026-06-181250PUT0 054.91FALSE00
2026-06-181300PUT0 255.1FALSE00
2026-06-181350PUT0 054.84FALSE00
2026-06-181400PUT0 054.36FALSE00
2026-06-181450PUT0 054.57FALSE00
2026-06-181500PUT0 053.71FALSE00
2026-06-181550PUT0 053.53FALSE00
2026-06-181600PUT0 053.16FALSE00
2026-06-181650PUT0 052.63TRUE00
2026-06-181700PUT0 052.32TRUE00
2026-06-181750PUT0 051.87TRUE00
2026-06-181800PUT0 051.64TRUE00
2026-06-181850PUT0 051.26TRUE00
2026-06-181900PUT0 050.73TRUE00
2026-06-181950PUT0 050.81TRUE00
2026-06-182000PUT0 050TRUE00
2026-06-182100PUT0 049.49TRUE00
2026-06-182200PUT0 049.28TRUE00
2026-06-182300PUT0 048.43TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm